Type 1 Diabetes and Cardiovascular Health.

Cardiovascular disease risk Cardiovascular health Prevention Type 1 diabetes

Journal

Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104

Informations de publication

Date de publication:
Mar 2024
Historique:
medline: 26 1 2024
pubmed: 26 1 2024
entrez: 25 1 2024
Statut: ppublish

Résumé

Type 1 diabetes (T1D) is associated with an increased risk of cardiovascular disease (CVD). CVD occurs much earlier in people with T1D than in the general population, and several risk factors have been identified some of which are modifiable. Risk prediction models and imaging tests to detect early signs of CVD have not been extensively validated. Strategies to promote cardiovascular health (CVH) in T1D include identifying risk factors, early treatment to achieve CVH targets, and improving the education of health care providers and people with T1D.

Identifiants

pubmed: 38272593
pii: S0889-8529(23)00058-0
doi: 10.1016/j.ecl.2023.07.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-163

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure No competing financial interests exist.

Auteurs

Maria Pesantez (M)

Jackson Memorial Hospital, 1450 Northwest 10 Avenue, Miami, FL 33136, USA.

Osagie Ebekozien (O)

T1D Exchange, 101 Federal Street Suite 440, Boston, MA 02110, USA.

Francesco Vendrame (F)

Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine, 1450 Northwest 10 Avenue, Room 1086, Miami, FL 33136, USA. Electronic address: fvendrame@med.miami.edu.

Classifications MeSH